Nicox Science Ireland
Records under this name other than patents Nicox Science Ireland holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,754,772 | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,691,869 | Pharmaceutical formulation of nitrooxyderivatives of NSAIDs Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,003,811 | Nitric oxide donor compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,061,962 | Quinone based nitric oxide donating compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,079,821 | Quinone based nitric oxide donating compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,446,015 | Quinone based nitric oxide donating compounds for ophthalmic use Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,093,696 | Nitric Oxide Donating Carnosine Compounds Formerly held Lapsed on the fee record Ended Oct 9, 2026 · High confidence | Lapsed on the fee record | Ended Oct 9, 2026 | High confidence |
| US 9,895,335 | Ophthalmic compositions containing a nitric oxide donor Formerly held Lapsed on the fee record Ended Feb 20, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 20, 2026 | USPTO record |
| US 9,598,349 | Quinone based nitric oxide donating compounds for ophthalmic use Formerly held Lapsed on the fee record Ended Mar 21, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 21, 2025 | USPTO record |
| US 9,266,820 | Nitric oxide donor compounds Formerly held Lapsed on the fee record Ended Feb 23, 2024 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2024 | USPTO record |